Curated News
By: NewsRamp Editorial Staff
November 05, 2024
GeoVax to Host Conference Call at 4:30 PM ET
Discuss on Reddit
LinkedIn
Substack
TelegramTLDR
- Investors can gain insights and advantages by participating in GeoVax's live conference call and webcast.
- The conference call will provide detailed updates on GeoVax's financial results and corporate progress.
- GeoVax's innovative vaccines and therapies contribute to improving global health and fighting infectious diseases and cancers.
- GeoVax's research into next-generation COVID-19 vaccine and novel oncolytic solid tumor gene-directed therapy is cutting-edge and impactful.
Impact - Why it Matters
This news matters as it provides an opportunity for investors and stakeholders to gain insights into GeoVax's financial performance and ongoing developments in the development of novel vaccines for infectious diseases and therapies for solid tumor cancers, including a next-generation COVID-19 vaccine.
Summary
GeoVax Labs, Inc. will report third quarter 2024 financial results on November 12, 2024, after the close of U.S. markets. Management will host a live conference call and webcast at 4:30 p.m. ET to provide a corporate update and discuss financial results. Participants may register for the live conference call and webcast here. The company is developing novel vaccines for infectious diseases and therapies for solid tumor cancers, with a lead clinical program focused on a next-generation COVID-19 vaccine.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, GeoVax to Host Conference Call at 4:30 PM ET
